期刊文献+

上皮性卵巢癌中P73蛋白、P21^(WAF1/CIP1)蛋白、PCNA蛋白的表达及其相关性 被引量:1

Expressions of P73 protein,P21^(WAF1/CIP1) protein and PCNA protein in epithelial ovarian cancer and their correlation
原文传递
导出
摘要 目的:探讨上皮性卵巢癌中P73蛋白、P21WAF1/CIP1蛋白与PCNA蛋白的表达及其相关性,为卵巢癌的临床诊断及治疗包括基因治疗提供实验依据。方法:采用Eli Visionplus免疫组化研究40例上皮性卵巢癌组织、15例正常卵巢组织、25例良性上皮性卵巢肿瘤组织、7例交界性上皮性卵巢肿瘤组织中P73蛋白、P21WAF1/CIP1蛋白与PCNA蛋白的表达。结果:随着上皮性卵巢癌病理学分级及临床分期增高,①P73蛋白表达率增高,差异有统计学意义(P<0.05);但不同病理类型之间差异无统计学意义,在良性上皮性卵巢肿瘤与上皮性卵巢癌差异有统计学意义(P<0.05);②P21WAF1/CIP1蛋白表达率降低,差异有统计学意义(P<0.05);但不同病理类型之间无统计学差异,在良性上皮性卵巢肿瘤与上皮性卵巢癌差异有统计学意义(P<0.05);③PCNA蛋白表达率增高,差异有统计学意义(P<0.05);但不同病理类型之间无统计学差异,在良性上皮性卵巢肿瘤与上皮性卵巢癌差异有统计学意义(P<0.05)。结论:①P73蛋白、PCNA蛋白表达在上皮性卵巢癌中阳性率升高,并随恶性程度增高而增高。②P21WAF1/CIP1蛋白表达在上皮性卵巢癌中阳性率降低,并随恶性程度增高而降低,与P73蛋白表达呈负相关。 Objective: To explore the expressions of P73 protein, P21^WAF1/CIP1 protein and PCNA protein in epithelial ovarian cancer aml their correlation, provide a experimental basis for clinical diagnosis and treatment (including gene therapy ) of ovarian cancer. Methods: The expression levels of P73 protein, P21^WAF1/CIP1 protein and PCNA protein in 40 cases with epithelial ovarian cancer, 15 cases with normal ovary, 25 cases with benign epithelial ovarian tumor and 7 cases with borderline epithelial ovarian tumor were detected by EliVision plus immunohistochemical method. Results: The expression rate of P73 protein increased significantly (P 〈 0. 05) , but there was no significant difference among dill)rent pathological types, there was significant differenee in expression rate of P73 protein between benign epithelial ovarian tumor and epithelial ovarian cancer (P 〈 0. 05 ) ; the expression rate of P21^WAF1/CIP1 protein decreased significantly ( P 〈 0. 05), but there was no significant difference among different pathological types, there was significant difference in expression rate of P21^WAF1/CIP1 protein between benign epithelial ovarian tumor and epithelial ovarian cancer (P 〈0. 05 ) ; the expression rate of PCNA protein increased significantly ( P 〈 0. 05 ) , but there was no significant difference among different pathological types, there was significant difference in expression rate of PCNA protein between benign epithelial ovarian tumor and epithelial ovarian cancer (P 〈 0. 05 ) . Conclusion: The positive expression rates of P73 protein and PCNA protein in epithelial ovarian cancer increase with the malignant aggression of epithelial ovarian eancer; the positive expression rate of P21^WAF1/CIP1 protein decreases with the malignant aggression of epithelial ovarian cancer, there is a negative correlation with P73 protein.
出处 《中国妇幼保健》 CAS 北大核心 2010年第13期1839-1841,共3页 Maternal and Child Health Care of China
基金 江西省卫生厅课题资助项目〔20051083〕
关键词 上皮性卵巢癌 免疫组化 P73蛋白 P21^WAF1/CIP1蛋白 PCNA蛋白 Epithelial ovarian cancer Immunohistochemistry P73 protein P21^WAF1/CIP1 protein PCNA protein
  • 相关文献

参考文献10

二级参考文献57

  • 1萨姆布鲁克J 弗里奇EF.分子克隆实验指南(第二版)[M].北京:科学出版社,1992..
  • 2[1]Igaki H, Saki H, Kishi T, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines [J]. Bioche Biophys Res Commun, 1994,203(2):1090-1095.
  • 3[2]Shimizu M, Saitch Y, Itoh H. Immunohistochemical staining of Ha-ras oncology product in normal, benign and malignant human pancreatic tissues [J]. Hum Pathol,1990,21(6):607-612.
  • 4[3]Max J. New tumor suppressor may rival p53 [J]. Science, 1994,264(5157):344-345.
  • 5[4]Wong YF, Chung TK, Cheung TH, et al. p16INK4 and p15INK4B alterations in primary gynecologic malignancy [J]. Gynecol Oncol,1997,65(2):319-324.
  • 6[5]Peiffer SL, Bbartsch D, Welan AJ, et al. Low frequency of CDKN2 mutation in endometrial carcinoma [J]. Mol Carcinog, 1995,13(4):210-212.
  • 7[6]Shiozawa T, Nikaido T, Shimizu M, et al. Immunohistochemical analysis of the expression of the expression of cdk4 and p16ink4 in human endometrioid-type endometrial carcinoma [J]. Cancer,1997,80(12):2250-2254.
  • 8[7]Mccluskcy LL, Chen C, Delgadillo E, et al. Differences in p16 gene methylation and expression in benign and malignant ovarian tumors [J]. Gynecol Oncol, 1999,72(1):87-92.
  • 9[8]Muscarella P, Melvin WS, Fisher WF, et al. Genetic alteration in gastrinomas and nonfunctioning pancreatic neuroendocrine tumor:an analysis of p16/MTS1 tumor suppressor gene inactivation [J]. Cancer Res, 1998,58(2):237-240.
  • 10[9]Okamoto A, Demeteick DJ, Spillare EA, ct al. Mutations and altered expression of p16INK4 in human cancer [J]. PNAS, 1994,91(23):11045-11049.

共引文献9

同被引文献25

  • 1力超,郑天荣,张红,陆丽俐,蔡晓雯.肝细胞癌中PTEN、p73蛋白表达及临床意义[J].中国肿瘤,2005,14(11):760-762. 被引量:1
  • 2Zwahlen D, Tschan M P,Grob T J, et al. Differential expression of P73 splice variants and protein in bengin and malignant ovarian tumours [J]. Int J Cancer, 2000,88 (1) : 66-70.
  • 3Niyazi M,Ghazizadeh M,Konishi H, et al. Expression of P73 and c-Abl proteins in human ovarian carcino- mas[J]. Nippon Med Sch,2003,70(3):234-242.
  • 4Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to P53 at lp36, a region frequently deleted in neuroblastoma and other human cancers[J]. Cell, 1997,90(2):809-819.
  • 5Scaruffi P,Casciano J, et al. Lack of expression in ma ture B-ALL and identification of three new spicing va- riants restricted to pre B and C-ALL indicate a role of P73 in B cell ALL differentiation[J]. Leukemia, 2000, 14(3) : 518-525.
  • 6De Laurenzi V, Costanzo A, Barearoli D, et al. Two new P73 splice variants, gamma and delta, with different transcriptional activity[J]. J Exp Med, 1998, 188 ( 9 ) : 1763-1768.
  • 7Kang M J, Park B J, Byun D S, et al. Loss of omprint- ing and elevated expression of wild-type P73 in human gastric adenocarcinoma[J]. Clin Cancer Res, 2000,6: 1767-1771.
  • 8Yokozaki H, Shitara Y, Fujimoto J Y, et al. Alterations of P73 preferentially occur in gastric adenocarcinomaswith foveolar epithelial phenotype[J]. Int J Cancer, 1999,83(2) : 192-196.
  • 9Zai Ka AI, Kovalev S, Marchenko N D, et al. Overex- pression of the wild type P73 gene in breast cancer tis-sues and cell lines[J]. Cancer Res, 1999,59( 13 ) :3257- 3263.
  • 10Zai Ka A I,Slade N,Erster S H,et al. NP73,a domi- nant-negative inhibitor of wild-type P53 and TAP73, is up-regulated in human tumors [ J ]. J Exp Med,2002,196(6):765-780.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部